Instem – “delighted with the continued successes of our organic and acquisitive growth strategies”. Er!
Describing itself as “a leading provider of IT solutions to the global life sciences market”, Instem (INS) states that it “announces a positive trading update for the six months to 30 June 2022”. How positive?
- By Steve Moore
- 2022-08-04 16:05:00